The current status of cancer survivorship care and a consideration of appropriate care model in Korea.
Hye Mi KoJe Ryong KimJin Sun LeePublished in: Korean journal of clinical oncology (2020)
A combination of local treatment modality for BCBM and the use of substances that cross the BBB for the HER2 enriched patient improved the survival rate.